Tremblay Frédéric, Gagnon AnneMarie, Veilleux Alain, Sorisky Alexander, Marette André
Department of Anatomy and Physiology and Lipid Research Unit, Laval University Hospital Research Center, 2705 Laurier Boulevard, Ste-Foy, Québec, Canada G1V 4G2.
Endocrinology. 2005 Mar;146(3):1328-37. doi: 10.1210/en.2004-0777. Epub 2004 Dec 2.
The mammalian target of rapamycin (mTOR) pathway has recently emerged as a chronic modulator of insulin-mediated glucose metabolism. In this study, we evaluated the involvement of this pathway in the acute regulation of insulin action in both 3T3-L1 and human adipocytes. Insulin rapidly (t(1/2) = 5 min) stimulated the mTOR pathway, as reflected by a 10-fold stimulation of 70-kDa ribosomal S6 kinase 1 (S6K1) activity in 3T3-L1 adipocytes. Inhibition of mTOR/S6K1 by rapamycin increased insulin-stimulated glucose transport by as much as 45% in 3T3-L1 adipocytes. Activation of mTOR/S6K1 by insulin was associated with a rapamycin-sensitive increase in Ser636/639 phosphorylation of insulin receptor substrate (IRS)-1 but, surprisingly, did not result in impaired IRS-1-associated phosphatidylinositol (PI) 3-kinase activity. However, insulin-induced activation of Akt was increased by rapamycin. Insulin also activated S6K1 and increased phosphorylation of IRS-1 on Ser636/639 in human adipocytes. As in murine cells, rapamycin treatment of human adipocytes inhibited S6K1, blunted Ser636/639 phosphorylation of IRS-1, leading to increased Akt activation and glucose uptake by insulin. Further studies in 3T3-L1 adipocytes revealed that rapamycin prevented the relocalization of IRS-1 from the low-density membranes to the cytosol in response to insulin. Furthermore, inhibition of mTOR markedly potentiated the ability of insulin to increase PI 3,4,5-triphosphate levels concomitantly with an increased phosphorylation of Akt at the plasma membrane, low-density membranes, and cytosol. However, neither GLUT4 nor GLUT1 translocation induced by insulin were increased by rapamycin treatment. Taken together, these results indicate that the mTOR pathway is an important modulator of the signals involved in the acute regulation of insulin-stimulated glucose transport in 3T3-L1 and human adipocytes.
雷帕霉素的哺乳动物靶点(mTOR)信号通路最近已成为胰岛素介导的葡萄糖代谢的一种慢性调节因子。在本研究中,我们评估了该信号通路在3T3-L1和人脂肪细胞中对胰岛素作用的急性调节中的参与情况。胰岛素迅速(t(1/2) = 5分钟)刺激mTOR信号通路,这在3T3-L1脂肪细胞中表现为70 kDa核糖体S6激酶1(S6K1)活性受到10倍的刺激。雷帕霉素抑制mTOR/S6K1可使3T3-L1脂肪细胞中胰岛素刺激的葡萄糖转运增加多达45%。胰岛素激活mTOR/S6K1与胰岛素受体底物(IRS)-1的Ser636/639磷酸化的雷帕霉素敏感性增加有关,但令人惊讶的是,并未导致与IRS-1相关的磷脂酰肌醇(PI)3激酶活性受损。然而,雷帕霉素可增加胰岛素诱导的Akt激活。胰岛素还可激活人脂肪细胞中的S6K1,并增加IRS-1在Ser636/639位点的磷酸化。与鼠细胞一样,用雷帕霉素处理人脂肪细胞可抑制S6K1,减弱IRS-1的Ser636/639磷酸化,导致胰岛素诱导的Akt激活增加和葡萄糖摄取增加。在3T3-L1脂肪细胞中的进一步研究表明,雷帕霉素可阻止IRS-1因胰岛素作用而从低密度膜重新定位到细胞质中。此外,抑制mTOR可显著增强胰岛素增加PI 3,4,5-三磷酸水平的能力,同时伴随着Akt在质膜、低密度膜和细胞质中的磷酸化增加。然而,雷帕霉素处理并未增加胰岛素诱导的GLUT4或GLUT1转位。综上所述,这些结果表明mTOR信号通路是3T3-L1和人脂肪细胞中胰岛素刺激的葡萄糖转运急性调节相关信号的重要调节因子。